Evidence map›Paper›PMID 21072603›Full record

Trial reportWiener klinische Wochenschrift2010

Cognitive function in elderly marathon runners: cross-sectional data from the marathon trial (APSOEM).

Robert Winker, Ina Lukas, Thomas Perkmann, Helmut Haslacher, Elisabeth Ponocny, Johann Lehrner, Dimiter Tscholakoff, Peter Dal-Bianco

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Wiener klinische Wochenschrift, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Changes of Mood and Cognitive Performance before and after a 100 km Nighttime Ultramarathon Run.International journal of environmental research and public health · 2020
    Article
  10. (Neuro) Peptides, Physical Activity, and Cognition.Journal of clinical medicine · 2020
    Review
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Article
  16. Article
  17. SOD2 in mitochondrial dysfunction and neurodegeneration.Free radical biology & medicine · 2013
    Review
  18. Article
  19. Article
  20. Systemic and cerebral hemodynamics during cognitive testing.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Robert WinkerUnit of Occupational Medicine, Medical University of Vienna, Vienna, Austria. robert.winker@meduniwien.ac.at
Ina Lukas
Thomas Perkmann
Helmut Haslacher
Elisabeth Ponocny
Johann Lehrner
Dimiter Tscholakoff
Peter Dal-Bianco
Medical University of Vienna · ATSigmund Freud University Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCognitive impairment of the elderly contributes to morbidity, loss of quality of life, and impairment of work ability in aging western societies. Thus strategies to maintain cognitive function at an advanced age imply a great challenge to Occupational Medicine.

aimTo study whether intensive endurance exercise training is associated with better cognitive performance and increases brain-derived neurotrophic factor (BDNF) and insulin-like growth factor (IGF).

methodsActive elderly marathon runners or bicyclists older than 60 years were recruited and matched with an inactive control group according to age, sex, and education years. After exclusion of various diseases according to the study protocol 56 athletes and 58 controls could be selected for follow-up studies. The influence of endurance training on cognitive function was assessed by the use of the Vienna Neuropsychological Test Battery and the CERAD test battery. Other relevant outcomes were the levels of BDNF, IGF-1, Apo e4 carrier state, and self-ratings.

resultsThe elderly marathon group performed better only in one specific cognitive task (the Five Point Test, p = 0.04) and almost significantly better in one additional test (the NAI Stroop Test, p = 0.08). Neither BDNF nor IGF-1 was related to the duration of daily exercise and no differences in the basal levels of these humoral growth factors in the exercise and the control cohort were found. Interestingly, we also found significantly decreased BDNF levels in subjects with Alzheimer's disease in the family in spite of the maintained normal cognitive performance (p = 0.01).

conclusionThese results suggest that extensive endurance exercise training might be beneficial for maintaining cognitive function in elderly persons. Our data demonstrate that beneficial endurance training effects are not linked to the upregulation of the examined neurotrophins. Since we found reduced BDNF-levels in subjects with a positive family history of Alzheimer's disease, we speculate that BDNF-reduction might precede cognitive impairment.

Indexed as

CognitionRunningBrain-Derived Neurotrophic FactorCognition DisordersCross-Sectional StudiesExercise TherapyFemaleHumansMaleMiddle AgedSomatomedinsBrain-Derived Neurotrophic FactorSomatomedins

Identifiers

PMID21072603
OpenAlexW2021801271

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.